tiprankstipranks
B.R.A.I.N. Biotechnology Research and Information Network AG (DE:BNN)
XETRA:BNN
Germany Market
Want to see DE:BNN full AI Analyst Report?

B.R.A.I.N. Biotechnology Research and Information Network (BNN) Stock Forecast & Price Target

12 Followers
See the Price Targets and Ratings of:

BNN Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
B.R.A.I.N.
Biotechnology Research and Information Network
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BNN Stock 12 Month Forecast

There Are No Analyst Ratings for DE:BNN In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

BNN Financial Forecast

BNN Earnings Forecast

The previous quarter’s earnings for BNN were -€0.29.
The previous quarter’s earnings for BNN were -€0.29.

BNN Sales Forecast

The previous quarter’s earnings for BNN were €11.48M.
The previous quarter’s earnings for BNN were €11.48M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on DE:BNN
Kepler Capital
Kepler Capital
€5
Buy
100.00%
Upside
Reiterated
02/25/26
B.R.A.I.N. Biotechnology Research and Information Network (0RFI) Gets a Buy from Kepler Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on DE:BNN
Kepler Capital
Kepler Capital
€5
Buy
100.00%
Upside
Reiterated
02/25/26
B.R.A.I.N. Biotechnology Research and Information Network (0RFI) Gets a Buy from Kepler Capital
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering B.R.A.I.N. Biotechnology Research and Information Network

3 Months
Nicolas PauillacKepler Capital
Success Rate
3/7 ratings generated profit
43%
Average Return
+16.71%
Copying Nicolas Pauillac's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +16.71% per trade.
1 Year
Nicolas PauillacKepler Capital
Success Rate
3/7 ratings generated profit
43%
Average Return
+5.80%
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +5.80% per trade.
2 Years
Nicolas PauillacKepler Capital
Success Rate
5/7 ratings generated profit
71%
Average Return
+14.91%
Copying Nicolas Pauillac's trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +14.91% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BNN Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
2
2
1
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
2
1
0
0
In the current month, BNN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BNN average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

BNN Stock Forecast FAQ

What is DE:BNN’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:BNN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:BNN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is B.R.A.I.N. Biotechnology Research and Information Network AG a Buy, Sell or Hold?
      Currently, no data Available
      What is B.R.A.I.N. Biotechnology Research and Information Network AG’s share price target?
      Currently, no data Available
      What do analysts say about B.R.A.I.N. Biotechnology Research and Information Network AG?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of B.R.A.I.N. Biotechnology Research and Information Network AG?
      To buy shares of DE:BNN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.